Need professional-grade analysis? Visit stockanalysis.com
$18.28B
20.96
3,317
0.17%
Price Chart
Risk-Adjusted Performance
Liaoning Cheng Da Co Ltd (600739) Price Performance
Liaoning Cheng Da Co Ltd (600739) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CNY11.05, down 4.74% from the previous close.
Over the past year, 600739 has traded between a low of CNY9.48 and a high of CNY13.34. The stock has gained 3.2% over this period. It is currently 17.2% below its 52-week high.
Liaoning Cheng Da Co Ltd has a market capitalization of $18.28B, with a price-to-earnings ratio of 20.96 and a dividend yield of 0.17%.
About Liaoning Cheng Da Co Ltd
Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; rabies vaccines for human use and inactivated Japanese encephalitis vaccines for human use; medical industry investment and medical enterprise management consulting; and computer software and hardware technology development, technology consulting, technology transfer, technical services, and selling of medical equipment and other businesses. The company was founded in 1991 and is headquartered in Dalian, China.
Company Info
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- SHG
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $11.12B
- EBITDA
- $250.78M
- Profit Margin
- 7.76%
- EPS (TTM)
- 0.57
- Book Value
- 19.32
Technical Indicators
- 52 Week High
- CN¥13.58
- 52 Week Low
- CN¥9.12
- 50 Day MA
- CN¥12.15
- 200 Day MA
- CN¥12.00
- Beta
- 0.91
Valuation
- Trailing P/E
- 20.96
- Forward P/E
- 24.94
- Price/Sales
- 1.65
- Price/Book
- 0.63
- Enterprise Value
- $23.32B